INTRODUCTION
Anti-bacterial peptides are one of the important factors in the innate immunity of vertebrates and invertebrates. They have been isolated from mammals [1] , amphibians [2] , insects [3] and chelicerates [4] . The search for novel anti-bacterial agents has become especially urgent because of the rapid spread of antibioticresistant pathogenic bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) and multi-antibiotic-resistant Pseudomonas aeruginosa, which cause serious problems in hospitals, especially in Japan. Most anti-bacterial peptides have broadspectrum activities and disrupt bacterial membranes via a peptide-lipid interaction, unlike the mechanism of action of antibiotics used currently [5] . Some anti-bacterial peptides have been shown to be effective against antibiotic-resistant bacteria [6] [7] [8] , suggesting their potential use as therapeutic agents. The cytotoxicity and antigenicity of these peptides, however, make them unsuitable for direct therapeutic use. Thus considerable attention has been focused on modifying their size and anti-bacterial activity. -Enantiomers of cecropin A, magainin and melittin are as active as their parent peptides [9] . Hybrid peptides of cecropin A and melittin displayed higher anti-bacterial activity and a broader spectrum than the parent cecropin A, and show no haemolytic activity [10] . Furthermore, shortened cecropin A-melittin hybrid peptides (e.g. a 15-mer peptide) were found to have strong anti-bacterial activity [11] . An analogue of indolicidin, in which five tryptophan residues were replaced with Abbreviations used : MRSA, methicillin-resistant Staphylococcus aureus ; 19L-30R-NH 2 fragment, peptide fragment with the sequence LCAAHCLAIGRR-NH 2 ; 22A-30R-NH 2 fragment, peptide fragment with the sequence AHCLAIGRR-NH 2 ; Fmoc, 9-fluorenylmethoxycarbonyl ; PEG-PS, poly(ethylene glycol)-polystyrene ; CL, cardiolipin ; PG, phosphatidylglycerol ; PE, phosphatidylethanolamine ; MIC, minimal inhibitory concentration. 1 To whom correspondence should be addressed (e-mail yamakawa!nises.affrc.go.jp).
removed from the N-terminus of the 19L-30R-NH # fragment (8-10-mer peptides) still had strong anti-bacterial activity. Deleting some amino acids from the C-terminal region of the fragment dramatically reduced activity, indicating that the Cterminal region of the 19L-30R-NH # fragment, i.e. RR-NH # , is important for exerting anti-bacterial activity. The AHCL-AIGRR-NH # (22A-30R-NH # ) fragment and its analogues exhibited about 3-fold and 9-12-fold higher activity against S. aureus than did the 19L-30R-NH # fragment, and these analogues were effective against methicillin-resistant S. aureus and Pseudomonas aeruginosa isolated from patients. These oligopeptides showed no haemolytic activity and did not inhibit the growth of murine fibroblast cells.
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phenylalanines, showed strong anti-bacterial activity that was free of haemolytic activity [12] . Many other truncated antibacterial peptides have also been synthesized [13] [14] [15] .
An understanding of the relationship between the structure and activity of anti-bacterial peptides is important in the development of new agents. In general, it is thought that the biological activity of amphipathic α-helical peptides results from their ability to form ion channels through membrane bilayers [16] . A study of the relationship between the secondary structure and biological activity of model short peptides (8-22-mer peptides) comprising leucine and lysine residues indicated that an amphipathic α-helical structure is an important condition for anti-bacterial activity [17] . The α-helical region of sapecin B, identified as the active site of this peptide, showed potent antimicrobial activity [18] , and its modified analogue, an 11-mer peptide composed of leucine and lysine residues, showed greater activity against micro-organisms, including MRSA [19] . Synthetic histatin analogues with enhanced amphipathicity of the helical conformation were shown to have broad, improved antimicrobial activity [20] .
We have previously isolated and characterized defensin from a beetle, Allomyrina dichotoma. This peptide is composed of 43 amino acid residues, and has been shown to be effective against MRSA [7] . In the present study, we determined the active centre of defensin by measuring the anti-bacterial activity of 64 overlapping 12-mer peptides derived from it, and investigated the mode of action of this fragment. We also synthesized truncated peptides and examined their anti-bacterial and cytotoxic activities. We found that some 9-mer analogues have greater antibacterial activity than the original peptide, but show no cytotoxic activity.
MATERIALS AND METHODS

Materials
9-Fluorenylmethoxycarbonyl (Fmoc) -amino acids and Fmoctris(alkoxy)benzylamide-PEG-PS resins [where PEG-PS is poly-(ethylene glycol)-polystyrene] were purchased from PerSeptive Biosystems. Phosphatidylglycerol (PG) from egg yolk lecithin, cardiolipin (CL) from bovine heart and phosphatidylethanolamine (PE) from Escherichia coli were obtained from Sigma. All other reagents were special-grade. Water was drawn from a Milli-Q system.
Peptide synthesis
The 64 overlapping 12-mer peptides, each offset by one residue, spanning the sequence of A. dichotoma defensin (VTCDLLSFE-AKGFAANHSLCAAHCLAIGRRGGSCERGVCICRR) with either a free carboxylate or a free amide group at their C-termini were synthesized by the multi-pin technique (Chiron Mimotopes, Clayton, Victoria, Australia) [21] . Other peptides were synthesized by the solid-phase method in a 9050 Plus peptide synthesizer (Millipore). Each peptide was purified to homogeneity by the SMART system or an A = KTA Explorer using a reversephase column of µRPC C2\C18 PC 3.2\3 or of Resource RPC (1 ml) (Pharmacia, Uppsala, Sweden). The column of µRPC C2\C18 PC 3.2\3 was eluted in 50 min at a flow rate of 0.1 ml\min, using a linear gradient from 0 to 30 % (v\v) acetonitrile in water, both containing 0.05 % (v\v) trifluoroacetic acid. The column of Resource RPC 1 ml was eluted in 20 min at flow rate of 2 ml\min, using a linear gradient from 0 to 25 % (v\v) acetonitrile in water, both containing 0.05 % (v\v) trifluoroacetic acid.
Anti-bacterial activity
Anti-bacterial activity assays were conducted in sterilized 96-well plates in a final volume of 100 µl as follows. Samples of 90 µl of suspensions of a mid-exponential-phase culture of bacteria in nutrient broth medium (Difco, Detroit, MI, U.S.A.) (A '!! l 0.001) were added to 10 µl of different concentrations of peptides dissolved in sterilized 10 mM sodium phosphate buffer, pH 7.0, containing 130 mM NaCl. The anti-bacterial activity of each peptide (50 µg\ml) was examined by measuring absorbance at 600 nm after incubation for 15 h at 25 mC. The minimal inhibitory concentration (MIC) of peptides was observed 20 h after incubation at 37 mC. Cysteine-containing peptides were alkylated with 4-vinylpyridine [22, 23] . The anti-bacterial activity of alkylated peptides was tested after purification by SMART using a reverse-phase column of µRPC C2\C18 PC 3.2\3. The bacteria used were Staphylococcus aureus ATCC 6538P, Esherichia coli JM109, MRSA and Pseudomonas aeruginosa. MRSA and P. aeruginosa were isolated from patients.
CD spectra
CD spectra were measured on a Jasco J-720 spectropolarimeter using a cell path length of 1 mm. Spectra were recorded at 25 mC in 10 mM sodium phosphate buffer, pH 7.0, containing 130 mM NaCl in the presence or absence of PG\CL (3 : 1 ; mol\mol) liposomes. Sixteen scans per sample were recorded over a wavelength range of 190-270 nm. The baseline (liposomes without peptide) was subtracted. Unilamellar liposomes were prepared as described by Matsuzaki et al. [24] . α-Helical content was estimated as described by Greenfield and Fasman [25] and Wu et al. [26] .
Liposomal membrane permeability assay
Liposomes containing trapped glucose were prepared as described by Yamada and Natori [18] . A sample of 2 µmol of phospholipids mixed in chloroform was dried under nitrogen gas, then 0.2 ml of 0.3 M glucose was added and multilamellar liposomes were prepared using a vortex mixer. Liposomes were washed three times with 10 mM sodium phosphate buffer (pH 7.0)\130 mM NaCl to remove untrapped glucose and finally suspended in 0.6 ml of the same buffer. The liposome suspension (15 µl) was added to different concentrations of peptides dissolved in 15 µl of the same buffer. Mixtures were incubated for 1 h at 25 mC. Phospholipids in liposomes were calculated by measuring the amount of ester groups [27] . Glucose released from liposomes was assayed using a Glucose CII-Test kit (Wako Chemical, Osaka, Japan). α-Lactalbumin was used as a negative control.
Haemolytic activity
Erythrocytes were isolated from heparinized rabbit blood by centrifugation at 800 g for 10 min after washing three times with isotonic PBS (130 mM NaCl, 3 mM KCl, 8 mM Na # HPO % and 1.5 mM KH # PO % , pH 7.4) and resuspended in the same buffer. Erythrocyte solution [0.5 % (v\v) ; final volume 100 µl] was incubated with different concentrations of peptides for 30 min at 25 mC. Samples were centrifuged at 1000 g for 5 min and the absorbance of supernatants was measured at 540 nm. Lysis obtained with 1 % (v\v) Triton X-100 was taken as 100 %. Melittin was used as a positive control.
Cytotoxic activity
The cytotoxic activity of peptides was examined in a sterile 96-well plate using the murine macrophage cell line JA-4 [28] and the fibroblast cell line L929 [29] . Cells were cultured at 37 mC in RPM1 1640 medium (Nissui, Tokyo, Japan) containing 10 % (v\v) fetal bovine serum, 100 µg\ml streptomycin and 100 units\ml penicillin in a 5 % CO # humidified atmosphere. Cultured cells were suspended in RPM1 medium (10& cells\ml) and 100 µl of cell suspension was transferred to culture plates. The mixture of PBS (10 µl) containing different concentrations of peptides and Alamar Blue (10 µl) (Iwaki, Chiba, Japan) was added to the cell suspension, which was then incubated at 37 mC for 24 h. Cell growth inhibition was determined by measuring fluorescence intensity on a Cytoflour 2300 (Millipore) at an excitation wavelength of 530 nm and an emission wavelength of 590 nm.
RESULTS
Anti-bacterial activity of synthetic peptides
To determine the active site of defensin, we synthesized 64 overlapping 12-mer peptides spanning the sequence of defensin with either a free carboxylate or a free amide group at their Ctermini, and studied the anti-bacterial activity of these peptides against S. aureus. Only one amidated peptide, corresponding to amino acid residues 19-30 of defensin, i.e. LCAAHCLAIGRR-NH # (19L-30R-NH # ), showed strong activity (100 % growth inhibition). Other peptides had less or no anti-bacterial activity. For example, the amidated fragments comprising amino acid residues 18-29 and 20-31 of defensin did not inhibit growth. The Synthetic bactericidal oligopeptides from Allomyrina dichotoma defensin MIC of the 19L-30R-NH # fragment is shown in Table 1 . The 19L-30R-NH # fragment showed anti-bacterial activity against Gram-positive bacteria (MIC of 18 µg\ml for S. aureus) and against Gram-negative bacteria (MIC of 48 µg\ml for E. coli). A 19L-30R fragment containing a free carboxylate group had no great activity against S. aureus (MIC of 50 µg\ml). The activity of these peptides was not affected by alkylation (results not shown). Anti-bacterial activity is not affected by either the free thiol groups in these peptides or by a disulphide bond.
CD spectra
The first nine amino acids of the 19L-30R-NH # fragment are identical with the C-terminus of the presumed α-helical structure region, by sequence identity with some other insect defensins [7] , suggesting that this fragment has the potential to form an α-helical structure. CD spectra of the 19L-30R-NH # fragment were measured using a spectropolarimeter in the absence or presence of PG\CL (3 : 1, mol\mol) liposomes. This fragment formed an α-helical structure in the lipidic environment, whereas it showed a random-coil structure in the absence of liposomes (Figure 1) . The α-helical content of the fragment was approx. 60 %.
Figure 2 Effect of the 19L-30R-NH 2 fragment on glucose release from liposomes
S. aureus (PG/CL, 3 : 1, mol/mol) (a) and E. coli (PE/PG/CL, 7 : 2 : 1, by mol) (b) types of liposomes with entrapped glucose were prepared. The amount of glucose released by 0.3 % Triton X-100 was defined as 100 %. The amount of glucose entrapped in liposomes was 1.3 mol of glucose/mol of S. aureus-membrane-type phospholipids and 1.2 mol of glucose/mol of E. coli-membrane-type phospholipids. The phospholipid concentration of the reaction mixture for the S. aureus-membrane-type was 236 µM and that for the E. coli-membrane-type was 214 µM. $, 19L-30R-NH 2 fragment ; , α-lactalbumin.
Membrane permeability
Most anti-bacterial peptides are known to interact with bacterial membranes [5] . We investigated the interaction of the 19L-30R-NH # fragment and its analogues with phospholipids. To do this, we prepared both S. aureus-and E. coli-membrane-type liposomes, i.e. the phospholipid composition for S. aureus was PG\CL (3 : 1, mol\mol) and that for E. coli was PE\PG\CL (7 : 2 : 1, by mol) [30] . The 19L-30R-NH # fragment displayed activity against liposomes of both phospholipid compositions (Figure 2 ). The amount of glucose leakage from liposomes depended on the peptide concentration. Glucose leakage from the S. aureus-membrane-type liposomes was greater than that from the E. coli-membrane-type liposomes. These results are consistent with anti-bacterial activity of the peptide.
Anti-bacterial activity of analogues of the 19L-30R-NH 2 fragment
The anti-bacterial activities of the 19L-30R-NH # fragment and of its analogues are summarized in Table 1 . The MICs of analogues against S. aureus were 1.8-3-fold higher than that of the 19L-30R-NH # fragment. The anti-bacterial activity of the analogues against E. coli was greater than or comparable with that of the 19L-30R-NH # fragment. Some indicated weak activity against MRSA.
The truncated peptides AAHCLAIGRR-NH # , AHCLA-IGRR-NH # and HCLAIGRR-NH # , which show deletions of 
Figure 3 Haemolytic activity of 22A-30R-NH 2 fragment analogues
Rabbit erythrocytes were incubated with different concentrations of the following synthetic peptides : #, ALRLAIRRR-NH 2 ; $, ALLLAIRRR-NH 2 ; , AWLLAIRRR-NH 2 ; , ALYLAIRRR-NH 2 ; =, ALWLAIRRR-NH 2 ; >, melittin. Details of experimental conditions are given in the Materials and methods section.
two, three and four amino acids respectively from the N-terminal region of the 19L-30R-NH # fragment, still had greater activity against S. aureus than did the 19L-30R-NH # fragment (MICs : AAHCLAIGRR-NH # , 5 µg\ml ; AHCLAIGRR-NH # , 6 µg\ml ; HCLAIGRR-NH # , 9 µg\ml). Peptides lacking C-terminal amino acids from the 19L-30R-NH # fragment (between one and four amino acids deleted) had no effect against S. aureus (results not shown), suggesting that the C-terminal structure of the 19L-30R-NH # fragment, RR-NH # , is important for anti-bacterial activity. Thus the truncated peptides had greater activity than the 19L-30R-NH # fragment. Because smaller peptides have an advantage for the design of therapeutic agents because of decreasing antigenicity, we synthesized five analogues of the 9-mer peptide AHCLAIGRR-NH # (22A-30R-NH # fragment) in order to obtain more effective anti-bacterial peptides. The antibacterial activities of these analogues are summarized in Table 2 . The activity of ALYLAIRRR-NH # against S. aureus (MIC 1.5 µg\ml) was 4-fold greater than that of the 22A-30R-NH # fragment, and 12-fold greater than that of the 19L-30R-NH # fragment. The other 9-mer analogues had 3-fold and 9-fold greater anti-bacterial activities (MIC 2 µg\ml) than 22A-30R-NH # and 19L-30R-NH # respectively. The anti-bacterial activity of the analogues against E. coli was about 5-10-fold greater than that of the original fragment. Four analogues showed antibacterial activity against MRSA. AWLLAIRRR-NH # showed the highest activity against MRSA (MIC 20 µg\ml). The MIC of
Figure 4 Cytotoxic activity of 22A-30R-NH 2 fragment analogues on macrophages
The murine macrophage cell line JA-4 was used to observe growth inhibition by the following 22A-30R-NH 2 analogues : #, ALRLAIRRR-NH 2 ; $, ALLLAIRRR-NH 2 ; , AWLLAIRRR-NH 2 ; , ALYLAIRRR-NH 2 ; =, ALWLAIRRR-NH 2 . For other experimental conditions, see the Materials and methods section.
A. dichotoma defensin against MRSA was 20 µg\ml when examined 10 h after incubation of the peptide [7] . These analogues were also active against P. aeruginosa isolated from a patient.
Haemolytic and cytotoxic activities of defensin analogues
All 9-mer analogues were tested for haemolytic activity against rabbit erythrocytes. No haemolytic activity was observed ( Figure  3) . Similar results were obtained with 12-mer analogues (results not shown). The cytotoxic activity of 9-mer analogues against mouse macrophages and fibroblasts was examined, and results indicated that these analogues had no cytotoxic activity against fibroblasts ( 2000 µg\ml peptide). Although AWLLAIRRR-NH # inhibited the growth of macrophages (20 % inhibition at 400 µg\ml and 80 % inhibition at 1 mg\ml), other 9-mer analogues did not show such inhibition (Figure 4 ).
DISCUSSION
In order to apply anti-bacterial peptides to the development of therapeutic agents, we looked for the active region of A. dichotoma defensin by measuring anti-bacterial activity against S. aureus. For this purpose, we synthesized 64 overlapping 12-mer peptides and examined their activity. Intact A. dichotoma defensin is known to be active against Gram-positive bacteria, but not against Gram-negative bacteria [7] . The 19L-30R-NH # fragment identified as an active region of defensin was effective against both Gram-positive and Gram-negative bacteria. The lipopolysaccharide of Gram-negative bacteria is reported to be a barrier for anti-bacterial peptides [31] , so deletion of the other amino acid sequences of the peptide may enable the 19L-30R-NH # fragment to bind efficiently to the membranes of Gramnegative bacteria.
The results of glucose leakage tests from liposomes clearly indicated that the target of the 19L-30R-NH # fragment is the bacterial membrane. Many basic anti-bacterial peptides have been reported to interact with liposomes containing acidic phospholipids and to change bacterial membrane permeability [5] . Liposomes with the phospholipid composition of Grampositive bacteria were more sensitive to the 19L-30R-NH # fragment than those mimicking Gram-negative bacteria ( Figure  2 ). The content of acidic phospholipids is higher in Grampositive compared with Gram-negative bacterial membranes Synthetic bactericidal oligopeptides from Allomyrina dichotoma defensin [30] . Thus we surmise that the 19L-30R-NH # fragment has a higher affinity for a bacterial membrane with a high content of acidic phospholipids. This was also supported by the MIC data for this peptide (Table 1) .
CD spectra showed that the 19L-30R-NH # fragment formed an α-helical structure in the presence of liposomes, and its α-helical content was estimated to be 60 %. The α-helical wheel projection of amino acid residues of the 19L-30R-NH # fragment indicated that the peptide forms a weak amphipathic structure (results not shown) [32] .
It has been suggested that amphipathic α-helical anti-bacterial peptides permeate the bacterial membrane by forming an ion channel [16] . However, recent studies on the mode of action of several anti-bacterial peptides showed that the peptides kill bacteria by a ' carpet-like ' mechanism [33] [34] [35] . The mechanism of anti-bacterial activity of the 19L-30R-NH # fragment remains to be elucidated.
We synthesized various analogues of the 19L-30R-NH # fragment by replacing amino acids in order to increase anti-bacterial activity. The results indicated that the enhanced anti-bacterial activity of peptides such as LRAAHRLAIGRR-NH # , LCAA-RCLAIGRR-NH # , LCAAHCLAILRR-NH # and LCAALCLA-IGRR-NH # is due to their increased helical amphipathicity. Enhanced segmental amphipathicity seen in further modified peptides, such as LLAAHLAIGRR-NH # and LCAAHCA-IRRR-NH # , induced strong activity. These two analogues may have detergent-like properties, due to enhanced hydrophobicity in their N-terminal region or enhanced hydrophilicity in their Cterminal region.
The results of peptide truncation indicated that the C-terminal region of 19L-30R-NH # , i.e. RR-NH # , is important for antibacterial activity. This region may be necessary for interaction with acidic phospholipids. All analogues derived from the 22A-30R-NH # fragment had cationic C-terminal regions and were rich in hydrophobic amino acids in their N-terminal portions. The 9-mer analogues may also act as a detergent to kill bacteria.
No analogue tested damaged murine erythrocytes (Figure 3 ) or fibroblasts significantly, suggesting an inability to lyse eukaryotic cells, whose outer leaflet is composed of zwitterionic and sphingomyelin phospholipids [36] . In addition, cholesterol in the membranes of eukaryotic cells may prevent peptides from disrupting the membrane [37] . In one case, an analogue strongly inhibited the growth of macrophages (Figure 4) . The second tryptophan residue in AWLLAIRRR-NH # may be the cause of its cytotoxicity towards macrophages, since ALLLAIRRR-NH # and ALWLAIRRR-NH # have no cytotoxic activity. In summary, in this study the 19L-30R-NH # fragment derived from A. dichotoma defensin was shown to exert anti-bacterial activity by permeabilizing the bacterial membrane. Some modifications of the 19L-30R-NH # fragment that enhanced helical or segmental amphipathicity resulted in increased anti-bacterial activity without haemolytic activity. These peptides were effective against pathogenic bacteria such as MRSA and P. aeruginosa isolated from patients, and could be used as lead peptides in the design of therapeutic agents. At present, the effect of a magainin analogue has been evaluated in clinical tests for the treatment of patients with diabetic ulcers [38] . Furthermore, analogues of sapecin B showed chemotherapeutic activity against MRSA in mice [39] . Finally, it is worth noting that the mechanisms of action of these peptides are totally different from those of any antibiotics used thus far. This difference enables insect antibacterial peptides to kill antibiotic-resistant pathogenic bacteria. We believe that a strategy to modify insect anti-bacterial peptides is an important approach to developing novel antibiotics.
